MTOR and Stroke: Some reports have suggested that suppressing the pharmacological effects of the mTOR pathway can regulate autophagy and result in neuroprotection, whereas other reports have suggested that the neurotoxicity of mTOR inhibitors is related to the promotion of autophagic processes, long-term activation of Akt, and activation of S6 kinase 1 (S6K1) occurring in brain cells after a stroke [154,156,157,158].